Global Apheresis Market to Surpass $6.8 Billion by 2032

Got story updates? Submit your updates here. ›

The global apheresis market is projected to reach a valuation of $6.88 billion by 2032, growing at a CAGR of 8.7% from 2024 to 2032. This growth is fueled by the increasing demand for plasma-derived products and advancements in apheresis technologies, particularly the integration of automation into apheresis devices.

Why it matters

Apheresis is a critical technology for collecting and processing vital blood components like plasma and platelets, which are essential for treating a wide range of medical conditions. The growth of the apheresis market reflects the rising global demand for these specialized therapeutic products and the healthcare industry's efforts to improve the efficiency and safety of blood collection and processing.

The details

Automated blood collection, or donor apheresis, accounts for over 76% of the global apheresis market revenue, driven by the need for efficient and reliable methods to collect blood components. Automated apheresis systems can collect multiple components simultaneously, optimizing donor time and resources. Europe leads the global apheresis market, capturing over 35% of total revenue in 2023, due to the expansion of specialized apheresis centers and the adoption of advanced technologies despite high costs.

• The global apheresis market was valued at $3,248.3 million in 2023.
• The market is projected to reach $6,882.1 million by 2032, growing at a CAGR of 8.7% from 2024 to 2032.